Evidence map›Paper›PMID 40941793›Full record

ArticlePlants (Basel, Switzerland)2025

Gap Analysis of Priority Medicinal Plant Species in the Kingdom of Saudi Arabia.

Ibrahim Jamaan Alzahrani, Joana Magos Brehm, Nigel Maxted

Abstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ibrahim Jamaan AlzahraniSchool of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0009-0002-9186-5722
Joana Magos BrehmSchool of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0002-6444-6488
Nigel MaxtedSchool of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicinal plant species are crucial biological resources, and yet their conservation in the Kingdom of Saudi Arabia remains insufficiently studied. This study conducts a comprehensive gap analysis of 74 priority medicinal plant species in the Kingdom of Saudi Arabia to assess their spatial distribution, identify conservation gaps and propose strategic recommendations. Occurrence records were collected from field surveys and global biodiversity databases, followed by ecogeographical land characterization and conservation gap analyses using the CAPFITOGEN3 tools. The results reveal significant disparities in in situ and ex situ conservation efforts, with two biodiversity hotspots, Asir and Jazan, containing the highest species diversity. While 66 species occur within protected areas, seven species are currently only recorded outside protected areas, indicating opportunities for expanding conservation efforts. Complementarity analysis identified 13 optimal protected areas for priority medicinal plants' conservation, alongside 20 potential sites outside protected areas that could serve as other effective area-based conservation measures. Ex situ conservation remains critically limited for many species, with only 10 represented in genebanks and all accessions currently stored internationally, although some medicinal plant species may have broader global distributions. To bring about improved outcomes of conservation, the expansion of in situ conservation coverage, integration of other effective area-based conservation measures, strengthening of national genebanks and leverage of biotechnology and geospatial tools is recommended by this study. The findings of this study can be used to develop a more systematic and sustainable approach to the conservation of medicinal plants in the Kingdom of Saudi Arabia.

Indexed as

complementarity analysisecogeographic land characterizationin situ and ex situ conservationmedicinal plantsSaudi Arabia

Identifiers

PMID40941793
PMCPMC12430436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.